Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1982 1
1983 1
1986 2
1987 2
1988 1
1989 2
1990 1
1992 2
1993 2
1994 2
1995 2
1996 2
1997 1
1998 3
1999 3
2000 11
2001 1
2002 2
2003 5
2004 5
2005 7
2006 6
2007 11
2008 11
2009 20
2010 16
2011 13
2012 23
2013 23
2014 23
2015 26
2016 27
2017 48
2018 59
2019 45
2020 70
2021 81
2022 96
2023 78
2024 92
2025 87

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

839 results

Results by year

Filters applied: . Clear all
Page 1
Hepatic IDH2 regulates glycolysis and gluconeogenesis.
Wang H, Xiong Q, He G, Tang J, Sun L, Cheng S, Ke M, Chen S, Hu Y, Feng J, Song L, Tong B, Zhang Z, Dai Z, Xu Y. Wang H, et al. Among authors: ke m. Metabolism. 2023 Jun;143:155559. doi: 10.1016/j.metabol.2023.155559. Epub 2023 Apr 11. Metabolism. 2023. PMID: 37044373
Single-cell RNA sequencing reveals the developmental program underlying proximal-distal patterning of the human lung at the embryonic stage.
Cao S, Feng H, Yi H, Pan M, Lin L, Zhang YS, Feng Z, Liang W, Cai B, Li Q, Xiong Z, Shen Q, Ke M, Zhao X, Chen H, He Q, Min M, Cai Q, Liu H, Wang J, Pei D, Chen J, Ma Y. Cao S, et al. Among authors: ke m. Cell Res. 2023 Jun;33(6):421-433. doi: 10.1038/s41422-023-00802-6. Epub 2023 Apr 21. Cell Res. 2023. PMID: 37085732 Free PMC article.
Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1-Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial.
Xu Q, Wang J, Sun Y, Lin Y, Liu J, Zhuo Y, Huang Z, Huang S, Chen Y, Chen L, Ke M, Li L, Li Z, Pan J, Song Y, Liu R, Chen C. Xu Q, et al. Among authors: ke m. J Clin Oncol. 2022 Jun 1;40(16):1795-1805. doi: 10.1200/JCO.21.02091. Epub 2022 Feb 22. J Clin Oncol. 2022. PMID: 35192397 Free PMC article. Clinical Trial.
839 results